BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21499809)

  • 21. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
    Lee DH; Kim HR; Kim DK; Park SI; Kim YH
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting early cancer-related deaths after curative esophagectomy for esophageal cancer.
    Matsumoto S; Takayama T; Wakatsuki K; Enomoto K; Tanaka T; Migita K; Ito M; Nakajima Y
    Am Surg; 2013 May; 79(5):528-33. PubMed ID: 23635590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.
    Kato H; Fukuchi M; Miyazaki T; Nakajima M; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(5):3461-7. PubMed ID: 16101164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy.
    Kosugi S; Ichikawa H; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
    J Surg Oncol; 2012 Jun; 105(8):767-72. PubMed ID: 22473575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
    Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-related mortality within the first year after subtotal esophagectomy for cancer.
    Pines G; Klein Y; Buyeviz V; Idelevich E; Kashtan H
    Ann Surg Oncol; 2011 Apr; 18(4):1139-44. PubMed ID: 21046267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
    Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
    Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
    Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
    World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
    Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
    Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
    Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
    Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
    Shim YM; Kim HK; Kim K
    J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.